Embedded Files
The Early Phase Clinical Cancer Prevention Consortium (ClinCaP) is part of the NCI Cancer Prevention Clinical Trials Network (CP-CTNet). The lead academic organization of ClinCaP is the University of Michigan and there are many Affiliated Organizations involved in trial development and conduct.
Welcome to ClinCaP
Welcome to ClinCaP
The Early Phase Clinical Cancer Prevention Consortium (ClinCaP) is a consortium of institutions administered by the University of Michigan. We develop and conduct Phase I and II trials for promising new agents with cancer preventive properties. The goal is to prioritize agents and optimize dosing for eventual testing in larger, Phase III trials.
Working Groups
Working Groups
The ClinCaP Consortium is organized around organ site working groups . The working groups allow researchers and clinicians from all our affiliated organizations to share their expertise and collaborate in the development of new trials.
Each working group has about 10-20 members, and they meet as needed by zoom calls to discuss new agents, cellular targets for cancer prevention, and relevant biomarker endpoints. At the present time we have four organ site working groups listed below.
Breast
Breast
The Breast Cancer Prevention Working Group is led by Dr. Carol Fabian and Dr. Bruce Kimler at the University of Kansas
Lower GI
Lower GI
The Lower GI Cancer Prevention Working Group is led by Dr. Carol Burke at Cleveland Clinic
Upper GI
Upper GI
The Upper GI Cancer Prevention Working Group is led by Dr. Amitabh Chak at Case Western Reserve University
Genito-urinary
Genito-urinary
The GU Cancer Prevention Working Group is led by Dr. Steven Clinton at the Ohio State University
Questions?
Questions?
Contact Michigan-ClinCaP-Trials-Group@med.umich.edu
to get more information about ClinCaP
Organizations Affiliated with ClinCaP
Organizations Affiliated with ClinCaP
Page updated
Google Sites
Report abuse